Members SAVE on Registration - Join or Renew Today

The Society for Immunotherapy of Cancer (SITC) members enjoy exclusive access and savings to SITC live events including the 35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020). 

SITC membership offers a variety of benefits throughout the year in addition to the Annual Meeting. Visit our benefits page to maximize your SITC membership. You may join or renew your membership through the Annual Meeting registration portal or visit our membership page

Student Members Receive Free Registration

In celebration of the society's 35th anniversary, all current student members of SITC will receive free registration to the 35th Anniversary Annual Meeting.

Pick Up Your Member Ribbon

Visit the member services kiosk to pick up your member ribbon. Long-time member ribbons are also available to recognize five-, 10-, 15- and 20-year members. Thank you for being part of the SITC family!   

Join the Presidential Membership Business Meeting

Join SITC President Mario Sznol, MD, and SITC Vice President Patrick Hwu, MD, for the Presidential Membership Business Meeting. Review highlights of the past year and learn more about the strategic direction of the society.  

Members are Our Core

SITC is the world's leading member-driven society dedicated to professionals working in the field of cancer immunotherapy. It is SITC's mission to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field.

As a SITC member, you will join a vibrant and growing network of research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders. 

Not a SITC Member?

If you are not yet a SITC member but would like to take advantage of discounted registration rates, click here to learn how to become a member of the leading member-driven organization dedicated solely to the cancer immunotherapy field.JoinSITC.jpg